India to Russia: Albendazole Export Trade Route
India has recorded 11 verified shipments of Albendazole exported to Russia, representing a combined trade value of $2.5M USD. This corridor is served by 3 active Indian exporters, with an average shipment value of $223.4K USD. The leading Indian exporter is IPCA LABORATORIES LIMITED, which accounts for 68% of total export value with 5 shipments worth $1.7M USD. On the buying side, HINCUS PHARMACEUTICALS is the largest importer in Russia with $1.7M USD in purchases. The top 3 suppliers — IPCA LABORATORIES LIMITED, IPCA LABORATORIES LIMITED , OXFORD LABORATORIES PRIVATE LIMITED — together control 100% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to Russia Albendazole corridor is one of India's established pharmaceutical export routes, with 11 shipments documented worth a combined $2.5M USD. The route is dominated by IPCA LABORATORIES LIMITED, which alone accounts for roughly 68% of all export value, reflecting the consolidated nature of India's albendazole manufacturing sector.
Across 3 active suppliers, the average shipment value stands at $223.4K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 72% of all shipments, consistent with albendazole's non-urgent bulk-order profile.
Shipment activity peaks during UNAVAILABLE, with an average transit time of 24 days port-to-port. The route has recorded an annual growth rate of 9%, placing it at rank #10 among India's top albendazole export destinations globally.
On the import side, key buyers of Indian albendazole in Russia include HINCUS PHARMACEUTICALS, HINCUS PHARMACEUTICALS , OOO PHARMVYSOTA and 1 others. HINCUS PHARMACEUTICALS is the single largest importer with 5 shipments valued at $1.7M USD.
